Exploratory Study on Lercanidipine Hydrochloride Polymorphism: pH-Dependent Solubility Behavior and Simulation of its Impact on Pharmacokinetics.

AAPS PharmSciTech
Ilia Alekseevich RepinGabriel L B de Araujo


This work describes an exploratory experimental and in silico study of the influence of polymorphism, particle size, and physiology on the pharmacokinetics of lercanidipine hydrochloride (LHC). Equilibrium and kinetic solubility studies were performed on LHC forms I and II, as a function of pH and buffer composition. GastroPlus® was used to evaluate the potential effect of solubility differences due to polymorphism, particle size, and physiological conditions, on the drug pharmacokinetics. The results indicated that solubilities of LHC polymorphs are strongly dependent on the composition and pH of the buffer media. The concentration ratio (CI/CII) is particularly large for chloride buffer (CI/CII = 3.3-3.9) and exhibits a slightly decreasing tendency with the pH increase for all other buffers. Based on solubility alone, a higher bioavailability of form I might be expected. However, exploratory PBPK simulations suggested that (i) under usual fasted (pH 1.3) and fed (pH 4.9) gastric conditions, the two polymorphs have similar bioavailability, regardless of the particle size; (ii) at high gastric pH in the fasted state (e.g., pH 3.0), the bioavailability of form II can be considerably lower than that of form I, unless the particle...Continue Reading


Aug 1, 1969·Journal of Pharmaceutical Sciences·A J Aguiar, J E Zelmer
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R Löbenberg, G L Amidon
Mar 21, 2001·Biological & Pharmaceutical Bulletin·M MoriharaH Ogata
Jul 28, 2001·Pharmaceutical Research·J BauerJ Morris
Sep 29, 2001·Advanced Drug Delivery Reviews·B AgoramM B Bolger
Nov 24, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Valquiria Aparecida Polisel JaborVera Lucia Lanchote
Mar 17, 2005·Journal of Pharmaceutical Sciences·Madhu Pudipeddi, Abu T M Serajuddin
Mar 10, 2006·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·T ShimataniS Tazuma
Jul 20, 2007·The Journal of Pharmacy and Pharmacology·Urban Fagerholm
Dec 7, 2007·Journal of Pharmaceutical and Biomedical Analysis·Edit BakaKrisztina Takács-Novák
Jul 16, 2010·Analytica Chimica Acta·Gergely VölgyiKrisztina Takács-Novák
Jan 22, 2014·Colloids and Surfaces. B, Biointerfaces·Nisharani S RanpiseVinod N Ghodake
Feb 5, 2015·The Journal of Pharmacy and Pharmacology·Sofia DomingosMaria Teresa Duarte
Oct 27, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Roberta Censi, Piera Di Martino
Oct 8, 2016·Biomacromolecules·Laura I Mosquera-GiraldoLynne S Taylor
Dec 3, 2016·Acta Pharmaceutica Sinica. B·Xiaomei Zhuang, Chuang Lu
Apr 4, 2017·Journal of Pharmaceutical and Biomedical Analysis·Wen-Peng Zhang, Dong-Ying Chen
Apr 1, 2016·Journal of Pharmaceutical Analysis·Darshan V ChaudharyPranav S Shrivastav
Feb 24, 2018·Journal of Pharmaceutical and Biomedical Analysis·Jamshed HaneefSanjay K Mandal
Mar 20, 2018·Journal of Pharmaceutical Sciences·Ting ZhangChuang Xie
May 4, 2018·Pharmaceutical Development and Technology·Janine Braga de SouzaNeila Márcia Silva-Barcellos
Sep 25, 2018·Journal of Clinical Pharmacology·Yasmin ThabetJörg Breitkreutz

❮ Previous
Next ❯

Methods Mentioned

equilibrium solubility studies

Software Mentioned

Opt Log D

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Dóra TempfliKrisztina Takács-Novák
Journal of Pharmaceutical Sciences
Madhu Pudipeddi, Abu T M Serajuddin
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Christel A S BergströmPer Artursson
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Jeremy PerrierGavin W Halbert
© 2021 Meta ULC. All rights reserved